Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Vanhove

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The Clinical Journal of Pain|July 15, 2011
NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgiaGordon A Irving, Miroslav Backonja, Richard Rauck, et al.
Diabetes Research and Clinical Practice|May 27, 2011
Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic painLynn R Webster, John F Peppin, Frederick T Murphy, et al.
Journal of Pain Research|January 17, 2012
Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic painJohn F Peppin, Kristine Majors, Lynn R Webster, et al.
Therapeutic Drug Monitoring|June 5, 2009
Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic painSunita Babbar, Jean-Francois Marier, Mohamad-Samer Mouksassi, et al.
The Journal of Pain|July 27, 2010
A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaLynn R Webster, T Philip Malan, Michael M Tuchman, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapyG F Vanhove, J M Gries, D Verotta, et al.
Journal of Pain and Symptom Management|June 12, 2010
Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic painDavid M Simpson, Suzanne Gazda, Stephen Brown, et al.
Pain Medicine (Malden, Mass.)|November 20, 2010
A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaGordon A Irving, Miroslav M Backonja, Edwin Dunteman, et al.
BMC Anesthesiology|December 21, 2011
Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgiaLynn R Webster, Margarita Nunez, Marvin D Tark, et al.
The Journal of Biological Chemistry|May 15, 1993
The CoA esters of 2-methyl-branched chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanic acids are oxidized by one single peroxisomal branched chain acyl-CoA oxidase in human liver and kidneyG F Vanhove, P P Van Veldhoven, M Fransen, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Clinical Journal of Pain|July 15, 2011
NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgiaGordon A Irving, Miroslav Backonja, Richard Rauck, et al.
Diabetes Research and Clinical Practice|May 27, 2011
Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic painLynn R Webster, John F Peppin, Frederick T Murphy, et al.
Journal of Pain Research|January 17, 2012
Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic painJohn F Peppin, Kristine Majors, Lynn R Webster, et al.
Therapeutic Drug Monitoring|June 5, 2009
Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic painSunita Babbar, Jean-Francois Marier, Mohamad-Samer Mouksassi, et al.
The Journal of Pain|July 27, 2010
A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaLynn R Webster, T Philip Malan, Michael M Tuchman, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapyG F Vanhove, J M Gries, D Verotta, et al.
Journal of Pain and Symptom Management|June 12, 2010
Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic painDavid M Simpson, Suzanne Gazda, Stephen Brown, et al.
Pain Medicine (Malden, Mass.)|November 20, 2010
A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaGordon A Irving, Miroslav M Backonja, Edwin Dunteman, et al.
BMC Anesthesiology|December 21, 2011
Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgiaLynn R Webster, Margarita Nunez, Marvin D Tark, et al.
The Journal of Biological Chemistry|May 15, 1993
The CoA esters of 2-methyl-branched chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanic acids are oxidized by one single peroxisomal branched chain acyl-CoA oxidase in human liver and kidneyG F Vanhove, P P Van Veldhoven, M Fransen, et al.
Pageof 4